Related Experiment Video
Updated: May 6, 2026

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
Published on: July 17, 2016
Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis
Daewoong Jo1, Danya Liu, Shan Yao
1Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Vanderbilt University Medical Center, 1161 21st Avenue South, A-5321 MCN, Nashville, Tennessee 37232, USA.
Abstract:
Suppressor of cytokine signaling (SOCS) 3 attenuates proinflammatory signaling mediated by the signal transducer and activator of transcription (STAT) family of proteins. But acute inflammation can occur after exposure to pathogen-derived inducers staphylococcal enterotoxin B (SEB) and lipopolysaccharide (LPS), or the lectin concanavalin A (ConA), suggesting that physiologic levels of SOCS3 are insufficient to stem proinflammatory signaling under pathogenic circumstances. To test this hypothesis, we developed recombinant cell-penetrating forms of SOCS3 (CP-SOCS3) for intracellular delivery to counteract SEB-, LPS- and ConA-induced inflammation. We found that CP-SOCS3 was distributed in multiple organs within 2 h and persisted for at least 8 h in leukocytes and lymphocytes. CP-SOCS3 protected animals from lethal effects of SEB and LPS by reducing production of inflammatory cytokines and attenuating liver apoptosis and hemorrhagic necrosis. It also reduced ConA-induced liver apoptosis. Thus, replenishing the intracellular stores of SOCS3 with CP-SOCS3 effectively suppresses the devastating effects of acute inflammation.
Insights
Suppressor of cytokine signaling 3 (SOCS3) is crucial for controlling inflammation. Researchers developed cell-penetrating SOCS3 (CP-SOCS3) to boost its levels, effectively reducing severe inflammation and protecting against lethal effects.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Suppressor of cytokine signaling 3 (SOCS3) normally limits pro-inflammatory signaling pathways like STAT.
- Physiological SOCS3 levels may be insufficient to control acute inflammation induced by pathogens (e.g., staphylococcal enterotoxin B [SEB], lipopolysaccharide [LPS]) or lectins (e.g., concanavalin A [ConA]).
Purpose of the Study:
- To develop and evaluate cell-penetrating SOCS3 (CP-SOCS3) as a therapeutic strategy to counteract acute inflammatory responses.
- To determine the efficacy of intracellular SOCS3 replenishment in mitigating pathogenic inflammation.
Main Methods:
- Development of recombinant cell-penetrating forms of SOCS3 (CP-SOCS3).
- Intracellular delivery of CP-SOCS3 in animal models exposed to SEB, LPS, and ConA.
- Assessment of CP-SOCS3 distribution, persistence, and its effects on inflammatory cytokine production, liver apoptosis, and necrosis.
Main Results:
- CP-SOCS3 demonstrated rapid distribution to multiple organs and sustained presence in leukocytes and lymphocytes.
- CP-SOCS3 administration protected animals from lethal SEB and LPS challenge by reducing inflammatory cytokines and liver damage.
- CP-SOCS3 effectively reduced ConA-induced liver apoptosis.
Conclusions:
- Intracellular delivery of SOCS3 using CP-SOCS3 is a viable strategy to suppress severe acute inflammation.
- Replenishing SOCS3 levels can counteract the detrimental effects of potent inflammatory inducers, offering a potential therapeutic avenue.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Regulation of Hematopoietic Stem Cells
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Cellular Injury V: Apoptosis and Autophagy